Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses

Date Published: 08-Feb-22

Authors: Steven S. Good, Ashleigh Shannon, Kai Lin, Adel Moussa, Justin G. Julander, Paolo La Colla, Gabriella Collu, Bruno Canard, Jean-Pierre Sommadossi
Journal: Antimicrobial Agents and Chemotherapy
DOI: 10.1128/AAC.00988-21
Cited AcceGen Product/Service: Huh-7

Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com

<<Previous Next>>

Cell

MicroRNA

Test and Analysis

Home > Publications >Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses >

Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses